163 related articles for article (PubMed ID: 37506762)
1. Analysis of pharma R&D productivity - a new perspective needed.
Schuhmacher A; Hinder M; von Stegmann Und Stein A; Hartl D; Gassmann O
Drug Discov Today; 2023 Oct; 28(10):103726. PubMed ID: 37506762
[TBL] [Abstract][Full Text] [Related]
2. Research and development productivity map: visualization of industry status.
Shimura H; Masuda S; Kimura H
J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
[TBL] [Abstract][Full Text] [Related]
3. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
[TBL] [Abstract][Full Text] [Related]
4. R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O
Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459
[TBL] [Abstract][Full Text] [Related]
5. Rebuilding the R&D engine in big pharma.
Garnier JP
Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
[TBL] [Abstract][Full Text] [Related]
6. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
[TBL] [Abstract][Full Text] [Related]
7. Pharma Success in Product DevelopmentâDoes Biotechnology Change the Paradigm in Product Development and Attrition.
Evens RP
AAPS J; 2016 Jan; 18(1):281-5. PubMed ID: 26475480
[TBL] [Abstract][Full Text] [Related]
8. Open innovation: A paradigm shift in pharma R&D?
Schuhmacher A; Gassmann O; Bieniok D; Hinder M; Hartl D
Drug Discov Today; 2022 Sep; 27(9):2395-2405. PubMed ID: 35643258
[TBL] [Abstract][Full Text] [Related]
9. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
Shimura H; Masuda S; Kimura H
Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
[TBL] [Abstract][Full Text] [Related]
10. Mergers and innovation in the pharmaceutical industry.
Comanor WS; Scherer FM
J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
[TBL] [Abstract][Full Text] [Related]
11. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
12. Changing R&D models in research-based pharmaceutical companies.
Schuhmacher A; Gassmann O; Hinder M
J Transl Med; 2016 Apr; 14(1):105. PubMed ID: 27118048
[TBL] [Abstract][Full Text] [Related]
13. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
14. The impact of mergers on pharmaceutical R&D.
LaMattina JL
Nat Rev Drug Discov; 2011 Aug; 10(8):559-60. PubMed ID: 21804580
[TBL] [Abstract][Full Text] [Related]
15. Do large mergers increase or decrease the productivity of pharmaceutical R&D?
Ringel MS; Choy MK
Drug Discov Today; 2017 Dec; 22(12):1749-1753. PubMed ID: 28646641
[TBL] [Abstract][Full Text] [Related]
16. Patent production is a prerequisite for successful exit of a biopharmaceutical company.
Saotome C; Nakaya Y; Abe S
Drug Discov Today; 2016 Mar; 21(3):406-9. PubMed ID: 26721189
[TBL] [Abstract][Full Text] [Related]
17. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
Janero DR
Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
[TBL] [Abstract][Full Text] [Related]
18. The upside of being a digital pharma player.
Schuhmacher A; Gatto A; Hinder M; Kuss M; Gassmann O
Drug Discov Today; 2020 Sep; 25(9):1569-1574. PubMed ID: 32554063
[TBL] [Abstract][Full Text] [Related]
19. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
20. Financial aspects and the future of the pharmaceutical industry in the United States of america.
Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
